-
Emergent to produce drug substance for J&Js Covid-19 vaccine
pharmaceutical-technology
July 07, 2020
Emergent BioSolutions has entered a five-year agreement with Johnson & Johnson unit Janssen Pharmaceutical for large-scale manufacturing of drug substance for the latter’s Covid-19 vaccine candidate, Ad26.COV2-S.
-
Britain nears $625 million Sanofi/GSK COVID-19 vaccine deal: report
expresspharma
July 07, 2020
Clinical trials are due to start in September and Sanofi has said it expects to get approval by the first half of next year, sooner than previously anticipated.
-
COVID-19 vaccine could be approved and available to public within six months: Poll
pharmaceutical-technology
July 03, 2020
The global spread of the COVID-19 pandemic and the resulting economic impact and public health burden has highlighted the urgent need for a vaccine to prevent the disease.
-
Zydus Cadila gets DCGI approval for human clinical trials of COVID-19 vaccine
expresspharma
July 03, 2020
The assent for human trials was given after the company submitted data of clinical trial on animals to the DCGI, in which the vaccine candidate was found to be successful with respect to safety and immunogenicity.
-
COVID-19 vaccines to enter late-stage trial by end of July: US’s top infectious diseases expert
expresspharma
July 03, 2020
The news comes as Moderna, which is at the forefront of the country’s vaccine development efforts, reiterated earlier in the day that a late-stage trial with 30,000 volunteers would begin this month.
-
ICMR-Bharat Biotech to expedite clinical trials of COVID-19 vaccine, plan launch by August 15
expresspharma
July 03, 2020
Presently, 12 clinical trial sites have been identified and ICMR has asked the institutions to enable subject enrolment by the first week of July.
-
First COVID-19 vaccine given green light for Phase I trial in China
europeanpharmaceuticalreview
July 02, 2020
CanSino Biologics’ Ad5-nCoV vaccine, a potential COVID-19 prophylactic, has been approved for study in a Phase I clinical trial in China.
-
iBio Receives IBM Clinical Development Solution
contractpharma
July 02, 2020
Designed to support clinical COVID-19 vaccine candidates.
-
Vaxart Signs MoU with AMS
contractpharma
July 02, 2020
Partnership enables production of one billion or more COVID-19 vaccine doses per year.
-
Inovio’s COVID-19 vaccine candidate shows promise in small early-stage trial
expresspharma
July 02, 2020
The vaccine induced immune responses in 34 of the 36 healthy volunteers aged 18 to 50 years, Inovio said.